Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study
Gut and Liver · 15.05.2025 · 19 (3) · 376-387
DOI: 10.5009/gnl240503 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Gut and Liver, online erschienen am 21.04.2025. Verfasst von Joo Hye Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Infliximab, Gastrointestinal Agents, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Society of Gastroenterology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
- Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea.
ORCID-Profile: Joo Hye Song, Sung Noh Hong, Myeong Gyu Kim, Minjung Kim, Seong Kyung Kim, Eun Ran Kim, Dong Kyung Chang, Young-Ho Kim
Förderung
- Korean Society of Gastroenterology
Zitieren
APA
Song, J. H., Hong, S. N., Kim, M. G., Kim, M., Kim, S. K., Kim, E. R., Chang, D. K., & Kim, Y. H. (2025). Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study. Gut and Liver, 19(3), 376-387. https://doi.org/10.5009/gnl240503
Vancouver
Song JH, Hong SN, Kim MG, Kim M, Kim SK, Kim ER, et al. Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study. Gut and Liver. 2025;19(3):376-387. doi:10.5009/gnl240503
BibTeX
@article{Song2025,
author = {Song, Joo Hye and Hong, Sung Noh and Kim, Myeong Gyu and Kim, Minjung and Kim, Seong Kyung and Kim, Eun Ran and Chang, Dong Kyung and Kim, Young-Ho},
title = {Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study},
journal = {Gut and Liver},
year = {2025},
volume = {19},
number = {3},
pages = {376--387},
doi = {10.5009/gnl240503}
}
EUVIMED